Tech Company Financing Transactions
Monopteros Therapeutics Funding Round
Monopteros Therapeutics closed a $20 million Series A financing round on 4/26/2021. Investors included Medicxi Ventures.
Transaction Overview
Company Name
Announced On
4/26/2021
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
78 Randolph Rd.
Chestnut Hill, MA 02467
USA
Chestnut Hill, MA 02467
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Monopteros Therapeutics has assembled a team of highly experienced drug developers, clinical researchers, and immunologists
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Francesco De Rubertis
Chief Executive Officer
Peter Keller
Chief Medical Officer
Arthur DeCillis
Co-Founder
Ulrich von Andrian
Browse more venture capital transactions:
Prev: 4/26/2021: Brella Insurance venture capital transaction
Next: 4/26/2021: Bizongo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs